Buscador de publicacions

Publicacions

  • Tappeiner C, Mesquida M, Adán A, Anton-Lopez J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou-Torrent R, García de Vicuña-Muñoz C and Heiligenhaus A.

    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

    JOURNAL OF RHEUMATOLOGY . 43(12): 2183-2188. Nº de cites: 73

    [doi:10.3899/jrheum.160231]

  • Ter Haar NM, Jeyaratnam J, Lachmann HJ, Simon A, Brogan PA, Doglio M, Cattalini M, Anton-Lopez J, Modesto C, Quartier P, Hoppenreijs E, Martino S, Insalaco A, Cantarini L, Lepore L, Alessio M, Calvo Penades I, Boros C, Consolini R, Rigante D, Russo R, Pachlopnik Schmid J, Lane T, Martini A, Ruperto N, Frenkel J, Gattorno M and Paediatric Rheumatology International Trials Organisation and Eurofever Project.

    The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

    ARTHRITIS & RHEUMATOLOGY . 68(11): 2795-2805. Nº de cites: 137

    [doi:10.1002/art.39763]

  • Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS and ARChiVe Investigators Network within the PedVas Initiative.

    Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

    ARTHRITIS & RHEUMATOLOGY . 68(10): 2514-2526. Nº de cites: 75

    [doi:10.1002/art.39729]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Borlan S, Gimenez-Roca C and Rivera J.

    Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population

    RHEUMATOLOGY INTERNATIONAL . 36(7): 905-910. Nº de cites: 26

    [doi:10.1007/s00296-016-3499-y]

  • Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton-Lopez J, Hofer M, Chkirate B, Bouayed K, Tugal-Tutkun I, Kuemmerle-Deschner J, Agostini H, Federici S, Arnoux A, Piedvache C, Ozen S and PEDBD group.

    Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD

    ANNALS OF THE RHEUMATIC DISEASES . 75(6): 958-964. Nº de cites: 148

    [doi:10.1136/annrheumdis-2015-208491]

  • Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Raad JJ, Jarosova K, Anton-Lopez J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO).

    Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

    JOURNAL OF RHEUMATOLOGY . 43(4): 816-824. Nº de cites: 35

    [doi:10.3899/jrheum.150430]

  • Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ, Anton-Lopez J, Paediatric Rheumatology International Trials Organisation, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group and Histiocyte Society.

    2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

    ARTHRITIS & RHEUMATOLOGY . 68(3): 566-576. Nº de cites: 181

    [doi:10.1002/art.39332]

  • Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N, Paediatric Rheumatology International Trials Organisation and the Pediatric Rheu, Leon K, Lheritier K and Abrams K.

    Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

    ARTHRITIS & RHEUMATOLOGY . 68(1): 218-228. Nº de cites: 93

    [doi:10.1002/art.39407]

  • Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.

    Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de cites: 14

  • Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Mellins ED, Ilowite NT, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg A, Wedderburn LR, Anton-Lopez J, Schwarz T, Hinks A, Bilginer Y, Park J, Cobb J, Satorius CL, Han B, Baskin E, Signa S, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, de Bakker PI, Raychaudhuri S, Langefeld CD, Thompson S, Zeggini E, Thomson W, Kastner DL, Woo P, International Childhood Arthritis Genetics (INCHARGE) Consortium and British Society of Pediatric and Adolescent Rheumatology BSPAR Study Group.

    HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 112(52): 15970-15975. Nº de cites: 106

    [doi:10.1073/pnas.1520779112]